NCT05700448 2026-02-05Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell LymphomaCStone PharmaceuticalsPhase 3 Not yet recruiting150 enrolled
NCT06617416 2025-03-12A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLCAkesoPhase 3 Recruiting560 enrolled
NCT04194801 2023-02-06A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular CarcinomaCStone PharmaceuticalsPhase 1/2 Completed26 enrolled 31 charts